SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA conducts inspection of FDC’s manufacturing unit at Roha

27 Mar 2023 Evaluate

United States Food and Drug Administration (USFDA) has inspected FDC’s manufacturing unit located at Roha, District Raigad, Maharashtra that manufactures Active Pharmaceutical Ingredient (APIs) products from March 20, 2023 to March 24, 2023. The said audit has been successfully completed by the USFDA with 'No observations' (Zero 483's). The Active Pharmaceutical Ingredients product manufactured at the said facility continues to be marketed in USA.

FDC made a modest beginning with marketing of vitamins and a range of prescription formulations. The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×